A series of studies unveiled at the American Society of Clinical Oncology annual meeting in Chicago found that GLP-1 medications, widely used to treat obesity and type 2 diabetes, were associated with lower rates of breast cancer, reduced cancer deaths and a decreased risk of cancer spreading
Kumar S, Xu J, Perkins C, Guo F, Snapper S, Finkelman FD, et al
Experience the rejuvenating effects of our skin-supporting ingredients
The 40mg is the whole tank , not one dose
This sparked research that eventually led to their approval as an obesity treatment in people with or without diabetes
A separate study in Sildenafil non-responders found that a notable portion of men with erectile dysfunction who did not respond to Sildenafil may see improvement with PT-141